This research examined the function and mechanism of FVTF in suppressing stemness of HCC cells, and found that FVTF inhibits HCC cell stem properties by targeting DNMT1/miR-34a-5p/FoxM1 axis, and indicating that FVTF is a potential therapeutic agent for human HCC. This evidence concerns the gene DNMT1 and hepatocellular carcinoma.